Cargando…
Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611589/ https://www.ncbi.nlm.nih.gov/pubmed/37789229 http://dx.doi.org/10.1007/s12325-023-02640-9 |
_version_ | 1785128523035312128 |
---|---|
author | Wong, Raymond Fishman, Jesse Wilson, Koo Yeh, Michael Al-Adhami, Mohammed Zion, Abigail Yee, Christopher W. Huynh, Lynn Duh, Mei Sheng |
author_facet | Wong, Raymond Fishman, Jesse Wilson, Koo Yeh, Michael Al-Adhami, Mohammed Zion, Abigail Yee, Christopher W. Huynh, Lynn Duh, Mei Sheng |
author_sort | Wong, Raymond |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10611589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-106115892023-10-29 Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison Wong, Raymond Fishman, Jesse Wilson, Koo Yeh, Michael Al-Adhami, Mohammed Zion, Abigail Yee, Christopher W. Huynh, Lynn Duh, Mei Sheng Adv Ther Correction Springer Healthcare 2023-10-04 2023 /pmc/articles/PMC10611589/ /pubmed/37789229 http://dx.doi.org/10.1007/s12325-023-02640-9 Text en © Springer Healthcare Ltd., part of Springer Nature 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Correction Wong, Raymond Fishman, Jesse Wilson, Koo Yeh, Michael Al-Adhami, Mohammed Zion, Abigail Yee, Christopher W. Huynh, Lynn Duh, Mei Sheng Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison |
title | Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison |
title_full | Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison |
title_fullStr | Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison |
title_full_unstemmed | Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison |
title_short | Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison |
title_sort | correction to: comparative effectiveness of pegcetacoplan versus ravulizumab and eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: a matching-adjusted indirect comparison |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611589/ https://www.ncbi.nlm.nih.gov/pubmed/37789229 http://dx.doi.org/10.1007/s12325-023-02640-9 |
work_keys_str_mv | AT wongraymond correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison AT fishmanjesse correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison AT wilsonkoo correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison AT yehmichael correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison AT aladhamimohammed correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison AT zionabigail correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison AT yeechristopherw correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison AT huynhlynn correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison AT duhmeisheng correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison |